KMT2A and acute lymphoblastic leukemia: In conclusion, the sustained transcription of TERRA may provide a yet-to-be-identified telomeric and/or extratelomeric advantage to MLL-r ALL as part of lymphoid transcriptional reprogramming associated with MLL rearrangements.